Acorda Therapeutics Inc (ACORQ)
0.605
+0.10
(+18.63%)
USD |
OTCM |
May 17, 16:00
Acorda Therapeutics Cash and Short Term Investments (Quarterly): 9.364M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 9.364M |
December 31, 2023 | 29.98M |
September 30, 2023 | 32.47M |
June 30, 2023 | 25.27M |
March 31, 2023 | 30.26M |
December 31, 2022 | 37.54M |
September 30, 2022 | 20.70M |
June 30, 2022 | 23.13M |
March 31, 2022 | 31.87M |
December 31, 2021 | 45.63M |
September 30, 2021 | 36.17M |
June 30, 2021 | 45.71M |
March 31, 2021 | 116.77M |
December 31, 2020 | 71.37M |
September 30, 2020 | 63.26M |
June 30, 2020 | 65.99M |
March 31, 2020 | 82.89M |
December 31, 2019 | 125.84M |
September 30, 2019 | 253.16M |
June 30, 2019 | 296.89M |
March 31, 2019 | 343.25M |
December 31, 2018 | 445.55M |
September 30, 2018 | 460.95M |
June 30, 2018 | 391.72M |
March 31, 2018 | 333.04M |
Date | Value |
---|---|
December 31, 2017 | 307.07M |
September 30, 2017 | 192.50M |
June 30, 2017 | 141.14M |
March 31, 2017 | 133.62M |
December 31, 2016 | 158.54M |
September 30, 2016 | 127.94M |
June 30, 2016 | 137.40M |
March 31, 2016 | 431.41M |
December 31, 2015 | 353.30M |
September 30, 2015 | 323.43M |
June 30, 2015 | 301.72M |
March 31, 2015 | 299.70M |
December 31, 2014 | 307.62M |
September 30, 2014 | 766.44M |
June 30, 2014 | 605.85M |
March 31, 2014 | 270.42M |
December 31, 2013 | 273.93M |
September 30, 2013 | 292.31M |
June 30, 2013 | 303.33M |
March 31, 2013 | 283.35M |
December 31, 2012 | 233.82M |
September 30, 2012 | 232.23M |
June 30, 2012 | 255.85M |
March 31, 2012 | 278.24M |
December 31, 2011 | 295.91M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
9.364M
Minimum
Mar 2024
296.89M
Maximum
Jun 2019
72.21M
Average
41.58M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
BioSig Technologies Inc | 0.293M |
Verve Therapeutics Inc | 606.37M |
Spectral AI Inc | 7.348M |
AIM ImmunoTech Inc | 13.07M |
Protalix BioTherapeutics Inc | 48.49M |